WAC

Samsung Bioepis Releases Second Quarter 2024 US Biosimilar Market Report

Retrieved on: 
Monday, April 8, 2024
Filgrastim, IRA, Trastuzumab, Pegfilgrastim, ASPS, Growth, Patient, Adalimumab, ASP, Market access, WAC, Medicare, FDA, CMS, Inflation, Economics, Food, Generic drug

The 5th edition explores some IRA implications on biosimilars along with latest price trends, biosimilars market share

Key Points: 
  • The 5th edition explores some IRA implications on biosimilars along with latest price trends, biosimilars market share
    INCHEON, Korea, April 08, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today released its Second Quarter 2024 Biosimilar Market Report , which includes the latest Average Sales Price (ASP) information of all biosimilars and reference products available in the US market.
  • This fifth-edition of the Samsung Bioepis Quarterly Biosimilar Market Report delves into some implications of the Inflation Reduction Act (IRA) with respect to biosimilars, as well as the biosimilars market share and price trends.
  • “Over the past year, we have strived to provide the US market with the latest biosimilar insights through our report, and we are grateful for the positive reception from our readers,” said Thomas Newcomer, Vice President, Head of Market Access, US, at Samsung Bioepis.
  • As of February 2024, adalimumab biosimilar market share has reached 4%, increasing 2% compared to the previous quarter.

University Credit Union Announces NIL Deal with Top California Baptist University Women's Basketball Player, Chloe Webb

Retrieved on: 
Monday, April 8, 2024
University Credit Union, UCU, Baptist University, Partnership, Athlete, Student, WAC, Conference, NIL, CBU, NCAA, Faculty

LOS ANGELES, April 8, 2024 /PRNewswire/ -- University Credit Union (UCU) is thrilled to announce its first name, image, and likeness (NIL) deal with Chloe Webb from California Baptist University (CBU) who has demonstrated outstanding athleticism and helped secure her teams' invitation to the NCAA tournament by winning the Western Athletic Conference (WAC) title in women's basketball. The deal is the first-ever NIL agreement secured during the WAC tournament and is UCU's first NIL agreement with a student-athlete.

Key Points: 
  • The deal is the first-ever NIL agreement secured during the WAC tournament and is UCU's first NIL agreement with a student-athlete.
  • Chloe accepted an NIL partnership offer that secures her membership with UCU and her participation in promoting the financial well-being of all members in the university community.
  • "I am so excited to be one of the first student athletes to have this amazing opportunity to partner with an organization like University Credit Union," Chloe Webb said.
  • The NIL agreement aligns with UCU's 70-plus-year commitment to the academic and athletic success of university and college communities nationwide.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of World Acceptance Corporation - WRLD

Retrieved on: 
Saturday, March 23, 2024
Consumer, WRLD, News, LLP, Pomerantz, WAC, Cryptocurrency

NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of World Acceptance Corporation (“WAC” or the “Company”) (NASDAQ: WRLD).

Key Points: 
  • NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of World Acceptance Corporation (“WAC” or the “Company”) (NASDAQ: WRLD).
  • On February 23, 2024, the Consumer Financial Protection Bureau announced that risks surrounding World Acceptance Corporation’s conduct warranted the need for federal supervision.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy

Retrieved on: 
Wednesday, March 20, 2024
Encephalitis, ICER, Bone marrow, Patient, DSM-IV codes, Urinary tract infection, Travel, Child, Health technology assessment, Therapy, Children's Hospital of Philadelphia, Central nervous system, Risk, MLD, Qualification, Health, WAC, NBS, Nerve, Mutation, UCSF, Disease, Federation, Research, Acquisition, Genome, Rash, Stem cell, HSC, Hospital, Family, Swelling, FDA, Diagnosis, HTA, Caregiver, Traffic barrier, Viral, Fever, Kyowa Kirin, PSLI, Liver, Government, San Raffaele Hospital, ARSA, Pharmaceutical industry

TOKYO, LONDON and BOSTON, March 20, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced the details of its U.S. commercial launch of Lenmeldy™ (atidarsagene autotemcel), formerly known as OTL-200, the first FDA-approved therapy for the treatment of children with pre-symptomatic late infantile (PSLI), pre-symptomatic early juvenile, (PSEJ), or early symptomatic early juvenile (ESEJ)—collectively referred to as early-onset—metachromatic leukodystrophy (MLD).

Key Points: 
  • Prior to Lenmeldy, there were no treatment options in the U.S. for early-onset MLD beyond supportive and end-of-life care.
  • This approach has the potential to restore enzymatic function to stop or slow disease progression with a single treatment.
  • Utilizing results from such studies, a multi-stakeholder working group is finalizing a nomination to add MLD to the U.S.
  • Based on current timelines and assumptions, Orchard Therapeutics expects the nomination will be submitted in mid-year 2024.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of World Acceptance Corporation - WRLD

Retrieved on: 
Friday, March 15, 2024
Consumer, Prior, News, LLP, Pomerantz, WAC, Cryptocurrency

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of World Acceptance Corporation (“WAC” or the “Company”) (NASDAQ: WRLD).

Key Points: 
  • NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of World Acceptance Corporation (“WAC” or the “Company”) (NASDAQ: WRLD).
  • On February 23, 2024, the Consumer Financial Protection Bureau announced that risks surrounding World Acceptance Corporation’s conduct warranted the need for federal supervision.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023

Retrieved on: 
Wednesday, March 27, 2024
Constitutional right, SAN, Research, Prior authorization, Acquisition, Lactic acid, Patient, Pregnancy, Fourth, Woman, Note, Security, WAC, OTCQB, Marketing, Citric acid, Medi-Cal, Beauty salon

SAN DIEGO, March 27, 2024 /PRNewswire/ -- The company behind Phexxi® (lactic acid, citric acid, and potassium bitartrate) vaginal gel, women's health innovator Evofem Biosciences, Inc. (OTCQB: EVFM), today announced financial results for the fourth quarter and year ended December 31, 2023. Highlights include:

Key Points: 
  • Highlights include:
    Delivered $18.2 million of Phexxi net product sales in 2023, an impressive increase compared to 2022 given the 73% reduction in field force and absence of growth capital in 2023.
  • Sales and marketing expense was 64% of net sales for 2023, a key milestone for the Company and a significant improvement from prior years.
  • For the year ended December 31, 2023, net product sales were $18.2 million compared to $16.8 million in net product sales in the prior year.
  • For the three months ended December 31, 2023, net product sales were $4.8 million compared to $0.2 million in the prior year period.

University Credit Union Announces First-Ever Athletic NIL Opportunity at 2024 Western Athletic Conference Basketball Tournament

Retrieved on: 
Wednesday, March 13, 2024
University Credit Union, UCU, Partnership, Student, WAC, Conference, Credit union, University, NIL, Basketball, Management

LOS ANGELES, March 13, 2024 /PRNewswire/ -- University Credit Union (UCU) is proud to present a revolutionary name, image, and likeness (NIL) opportunity to two basketball student-athletes who will compete at the 2024 Hercules Tires Western Athletic Conference (WAC) Basketball Tournament in Las Vegas. The deals will represent the first-ever NIL opportunities offered in the WAC's history.

Key Points: 
  • LOS ANGELES, March 13, 2024 /PRNewswire/ -- University Credit Union (UCU) is proud to present a revolutionary name, image, and likeness (NIL) opportunity to two basketball student-athletes who will compete at the 2024 Hercules Tires Western Athletic Conference (WAC) Basketball Tournament in Las Vegas.
  • At the conclusion of the March 13-16 tournament, UCU will select one men's basketball player and one women's basketball player from WAC member institutions as UCU student-athlete ambassadors.
  • UCU will then present the selected players with the opportunity to sign an NIL agreement with UCU.
  • The NIL opportunity in the sport of basketball is the latest partnership between UCU and the WAC in the college athletics world.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of World Acceptance Corporation - WRLD

Retrieved on: 
Thursday, March 7, 2024
Pomerantz, News, WRLD, LLP, Consumer, WAC, Cryptocurrency

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of World Acceptance Corporation (“WAC” or the “Company”) (NASDAQ: WRLD).

Key Points: 
  • NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of World Acceptance Corporation (“WAC” or the “Company”) (NASDAQ: WRLD).
  • On February 23, 2024, the Consumer Financial Protection Bureau announced that risks surrounding World Acceptance Corporation’s conduct warranted the need for federal supervision.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Dr. Roberta Bondar to address students at the upcoming World Affairs Conference (WAC) on Wednesday, March 6 at Upper Canada College. Presented in partnership with Branksome Hall, WAC is the longest-running, student-led conference in Canada

Retrieved on: 
Monday, March 4, 2024
TDSB, Greater Toronto Area, Interest, Female, Conference, School, COVID-19, Student, Accreditation, Branksome Hall, Upper Canada College, WAC

The day-long conference is co-hosted with Branksome Hall and features more than 10 speakers who will present on this year’s theme: WAC 2024: Minds in Motion.

Key Points: 
  • The day-long conference is co-hosted with Branksome Hall and features more than 10 speakers who will present on this year’s theme: WAC 2024: Minds in Motion.
  • The World Affairs Conference aims to bring together youths, educators, and changemakers to help shape a better world.
  • In a series of equity-based initiatives this year, the conference made registration free for TDSB students, expanding the reach of WAC.
  • New sustainability partner Farmer’s Edge makes the World Affairs Conference the first-ever, carbon-neutral, student-run conference in North America.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of World Acceptance Corporation - WRLD

Retrieved on: 
Wednesday, February 28, 2024
Pomerantz, Prior, News, LLP, Consumer, WAC, Cryptocurrency

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of World Acceptance Corporation (“WAC” or the “Company”) (NASDAQ: WRLD).

Key Points: 
  • NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of World Acceptance Corporation (“WAC” or the “Company”) (NASDAQ: WRLD).
  • On February 23, 2024, the Consumer Financial Protection Bureau announced that risks surrounding World Acceptance Corporation’s conduct warranted the need for federal supervision.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.